Clarivate Plc Q2 2026 Earnings Release

Clarivate Plc reported its financial results for the second quarter ended June 30, 2026. The company's total revenues were $587.3 million, a decrease from $621.4 million in the second quarter of 2025, primarily due to inorganic divestitures. Organic revenues decreased by 1.5%, with a 0.7% increase in organic subscription growth offset by lower organic transactional revenues. The net loss for the quarter was $268.6 million ($0.42 per diluted share), largely due to a $221.7 million non-cash goodwill impairment charge. Adjusted net income was $123.1 million ($0.19 per diluted share), compared to $123.3 million ($0.18 per diluted share) in the prior year's quarter. Adjusted EBITDA was $247.2 million, down from $261.6 million in Q2 2025. The company generated $44.0 million in free cash flow for the quarter. Clarivate reaffirmed its full-year 2026 financial outlook, expecting organic ACV growth of 2.0% to 3.0% and Adjusted EBITDA between $980 million and $1.04 billion. The company also announced a definitive agreement to divest its Life Sciences & Healthcare segment.